Turn Therapeutics (TTRX) Non Operating Income (2024 - 2026)

Turn Therapeutics' Non Operating Income history runs 3 years deep, the most recent figure standing at $275171.0 for Q1 2026.

• On a quarterly basis, Non Operating Income rose 387.46% year-over-year to $275171.0 in Q1 2026; TTM through Mar 2026 was $2.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.7 million, up 9181.3% from the prior year.
• Non Operating Income fell to $275171.0 in Q1 2026 per TTRX's latest filing, from $2.5 million in the prior quarter.
• Across five years, Non Operating Income topped out at $2.5 million in Q4 2025 and bottomed at $5827.0 in Q4 2024.
• The 3-year median for Non Operating Income is $32910.5 (2025), against an average of $471001.5.
• Biggest YoY gain for Non Operating Income was 42334.19% in 2025; the steepest drop was 43.07% in 2025.
• Year by year, Non Operating Income stood at $5827.0 in 2024, then surged by 42334.19% to $2.5 million in 2025, then tumbled by 88.87% to $275171.0 in 2026.
• Per Business Quant, the three latest TTRX Non Operating Income figures stand at $275171.0 (Q1 2026), $2.5 million (Q4 2025), and $9371.0 (Q3 2025).